Celastrol Induces Apoptosis and Autophagy via the AKT/mTOR Signaling Pathway in the Pituitary ACTH-secreting Adenoma Cells
Authors:
- 13 April 2022
- journal article
- research article
- Published by Springer Nature in Current Medical Science
- Vol. 42 (2) , 387-396
Abstract
Objective Pituitary adrenocorticotropic hormone (ACTH)-secreting adenoma is a relatively intractable endocrine adenoma that can cause a range of severe metabolic disorders and pathological changes involving multiple systems. Previous studies have shown that celastrol has antitumor effects on a variety of tumor cells via the AKT/mTOR signaling. However, whether celastrol has pronounced antitumor effects on pituitary ACTH-secreting adenoma is unclear. This study aimed to identify a new effective therapeutic drug for pituitary ACTH-secreting adenoma. Methods Mouse pituitary ACTH-secreting adenoma cells (AtT20 cells) were used as an experimental model in vitro and to establish a xenograft tumor model in mice. Cells and animals were administered doses of celastrol at various levels. The effects of celastrol on cell viability, migration, apoptosis and autophagy were then examined. Finally, the potential involvement of AKT/mTOR signaling in celastrol’s mechanism was assessed. Results Celastrol inhibited the proliferation and migration of pituitary adenoma cells in a time- and concentration-dependent manner. It blocked AtT20 cells in the G0/G1 phase, and induced apoptosis and autophagy by downregulating the AKT/mTOR signaling pathway. Similar results were obtained in mice. Conclusion Celastrol exerts potent antitumor effects on ACTH-secreting adenoma by downregulating the AKT/mTOR signaling in vitro and in vivo.Keywords
This publication has 46 references indexed in Scilit:
- The BCL-2 protein family, BH3-mimetics and cancer therapyCell Death & Differentiation, 2015
- Apoptosis, autophagy, necroptosis, and cancer metastasisMolecular Cancer, 2015
- Cushing's disease: current medical therapies and molecular insights guiding future therapiesNeurosurgical Focus, 2015
- Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo studyCell Death & Disease, 2015
- Caspase-9 as a therapeutic target for treating cancerExpert Opinion on Therapeutic Targets, 2014
- Traditional Chinese Medicine: A Treasured Natural Resource of Anticancer Drug Research and DevelopmentThe American Journal of Chinese Medicine, 2014
- Celastrol prevents cadmium‐induced neuronal cell death via targeting JNK and PTEN‐Akt/mTOR networkJournal of Neurochemistry, 2013
- Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 PhosphorylationScience, 2012
- HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible wayMolecular Cancer, 2010
- Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectorsEndocrine-Related Cancer, 2009